Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 3, 2009, Pages 379-386

  Qian, Yigang ^a   Deng, Junfang ^a   Xie, Haiyang ^a   Geng, Lei ^a   Zhou, Lin ^a   Wang, Yan ^a   Yin, Shenyong ^a   Feng, Xiaowen ^a   Zheng, Shusen ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Bladder cancer; IL 6; MAPK; PI3K; TLR4

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD14 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4;

ARTICLE; BLADDER CANCER; CANCER CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD14; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TOLL-LIKE RECEPTOR 4; URINARY BLADDER NEOPLASMS;

EID: 59449085221     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0478-z     Document Type: Article

References (30)

1. E Aksoy W Vanden Berghe S Detienne Z Amraoui KA Fitzgerald G Haegeman 2005 Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4 Eur J Immunol 5 7 2200 2209 10.1002/eji.200425801
2. JA Brown DM Dorfman FR Ma EL Sullivan O Munoz CR Wood 2003 Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 3 1257 1266
3. MR Cardillo P Sale F Di Silverio 2000 Heat shock protein-90, IL-6 and IL-10 in bladder cancer Anticancer Res 20 6B 4579 4583
4. H Dong G Zhu K Tamada L Chen 1999 B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 12 1365 1369 10.1038/70932
5. H Dong SE Strome DR Salomao H Tamura F Hirano DB Flies 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 8 793 800
6. EM El-Salahy 2002 Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients Clin Biochem 35 8 607 613 10.1016/S0009-9120(02)00382-X
7. GJ Feng HS Goodridge MM Harnett XQ Wei AV Nikolaev AP Higson 1999 Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase J Immunol 163 12 6403 6412
8. T Fukao S Koyasu 2003 PI3K and negative regulation of TLR signaling Trends Immunol 24 7 358 363 10.1016/S1471-4906(03)00139-X
9. C Gabay 2006 Interleukin-6 and chronic inflammation Arthritis Res Ther 8 Suppl 2 S3 10.1186/ar1917
10. M Guha N Mackman 2002 The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells J Biol Chem 277 35 32124 32132 10.1074/jbc.M203298200
11. NJ Horwood TH Page JP McDaid CD Palmer J Campbell T Mahon 2006 Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production J Immunol 176 6 3635 3641
12. B Huang J Zhao H Li KL He Y Chen SH Chen 2005 Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 65 12 5009 5014 10.1158/0008-5472.CAN-05-0784
13. DL Lamm 1992 Long-term results of intravesical therapy for superficial bladder cancer Urol Clin North Am 19 3 573 580
14. M Okamoto K Hattori R Oyasu 1997 Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro Int J Cancer 72 1 149 154 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D
15. W Oosterlinck B Lobel G Jakse PU Malmström M Stöckle C Sternberg 2002 European association of urology (EAU) working group on oncological urology. Guidelines on bladder cancer Eur Urol 41 2 105 112 10.1016/S0302-2838(01)00026-4
16. G Otto J Braconier A Andreasson C Svanborg 1999 Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection J Infect Dis 179 1 172 179 10.1086/314534
17. D Raghavan WU Shipley MB Garnick PJ Russell JP Richie 1990 Biology and management of bladder cancer N Engl J Med 322 16 1129 1138
18. PA Scherle EA Jones MF Favata AJ Daulerio MB Covington SA Nurnberg 1998 Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes J Immunol 161 10 5681 5686
19. T Seguchi K Yokokawa H Sugao E Nakano T Sonoda A Okuyama 1992 Interleukin-6 activity in urine and serum in patients with bladder carcinoma J Urol 148 3 791 794
20. X Shan A Hu H Veler S Fatma JS Grunstein S Chuang 2006 Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling Am J Physiol Lung Cell Mol Physiol 291 3 L324 L333 10.1152/ajplung.00056.2006
21. T Shimizu S Yokota S Takahashi Y Kunishima K Takeyama N Masumori 2004 Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells Clin Diagn Lab Immunol 11 5 969 976 10.1128/CDLI.11.5.969-976.2004
22. J Song MJ Duncan G Li C Chan R Grady A Stapleton 2007 A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells PLoS Pathog 3 4 e60 10.1371/journal.ppat.0030060
23. R Sun Z Tian S Kulkarni B Gao 2004 IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4 + T cell- and STAT3-dependent manners J Immunol 172 9 5648 5655
24. DA Tolley MK Parmar KM Grigor G Lallemand LL Benyon J Fellows 1996 The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up J Urol 155 4 1233 1238 10.1016/S0022-5347(01)66226-8
25. RM Vabulas H Wagner H Schild 2002 Heat shock proteins as ligands of toll-like receptors Curr Top Microbiol Immunol 270 169 184
26. AF Valledor M Comalada J Xaus A Celada 2000 The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation J Biol Chem 275 10 7403 7409 10.1074/jbc.275.10.7403
27. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci [Epub ahead of print]
28. DL Vredevoe M Widawski GC Fonarow M Hamilton O Martínez-Maza JR Gage 2004 Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure Am J Cardiol 93 8 1007 1011 10.1016/j.amjcard.2003.12.054
29. YD Wang J De Vos M Jourdan G Couderc ZY Lu JF Rossi 2002 Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells Oncogene 21 16 2584 2592 10.1038/sj.onc. 1205355
30. T Yokoyama A Komori M Nakamura Y Takii T Kamihira S Shimoda 2006 Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways Liver Int 26 4 467 476 10.1111/j.1478-3231.2006.01254.x